🎉 M&A multiples are live!
Check it out!

Selcuk Ecza Deposu Valuation Multiples

Discover revenue and EBITDA valuation multiples for Selcuk Ecza Deposu and similar public comparables like D1000 Varejo Farma, Sigma Healthcare, and Brasil Pharma.

Selcuk Ecza Deposu Overview

About Selcuk Ecza Deposu

Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.


Founded

1970

HQ

Turkey
Employees

6.5K+

Sectors

Pharmacies

Financials

LTM Revenue $3.9B

LTM EBITDA $130M

EV

$972M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Selcuk Ecza Deposu Financials

As of September 2025, Selcuk Ecza Deposu reported last 12-month revenue of $3.9B and EBITDA of $130M.

In the same period, Selcuk Ecza Deposu achieved $24.0M in LTM net income.

See Selcuk Ecza Deposu valuation multiples based on analyst estimates

Selcuk Ecza Deposu P&L

In the most recent fiscal year, Selcuk Ecza Deposu reported revenue of $3.1B and EBITDA of $150M.

Selcuk Ecza Deposu expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Selcuk Ecza Deposu valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $3.9B XXX $3.1B XXX XXX XXX
Gross Profit n/a XXX $311M XXX XXX XXX
Gross Margin n/a XXX 10% XXX XXX XXX
EBITDA $130M XXX $150M XXX XXX XXX
EBITDA Margin 3% XXX 5% XXX XXX XXX
EBIT n/a XXX $129M XXX XXX XXX
EBIT Margin n/a XXX 4% XXX XXX XXX
Net Profit $24.0M XXX $49.2M XXX XXX XXX
Net Margin 1% XXX 2% XXX XXX XXX
Net Debt XXX XXX $115M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Selcuk Ecza Deposu Stock Performance

Selcuk Ecza Deposu has current market cap of TRY 47.2B (or $1.1B), and EV of TRY 40.6B (or $972M).

Market Cap Evolution

Selcuk Ecza Deposu Stock Data

As of October 20, 2025, Selcuk Ecza Deposu's stock price is TRY 76 (or $2).

See Selcuk Ecza Deposu trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$972M $1.1B XXX XXX XXX XXX $0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Selcuk Ecza Deposu Valuation Multiples

Selcuk Ecza Deposu's trades at 0.3x EV/Revenue multiple, and 6.5x EV/EBITDA.

See valuation multiples for Selcuk Ecza Deposu and 15K+ public comps

Selcuk Ecza Deposu Financial Valuation Multiples

As of October 20, 2025, Selcuk Ecza Deposu has market cap of $1.1B and EV of $972M.

Equity research analysts estimate Selcuk Ecza Deposu's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Selcuk Ecza Deposu has a P/E ratio of 47.0x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $1.1B XXX $1.1B XXX XXX XXX
EV (current) $972M XXX $972M XXX XXX XXX
EV/Revenue 0.3x XXX 0.3x XXX XXX XXX
EV/EBITDA 7.5x XXX 6.5x XXX XXX XXX
EV/EBIT n/a XXX 7.6x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E 47.0x XXX 22.9x XXX XXX XXX
EV/FCF n/a XXX -4.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Selcuk Ecza Deposu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Selcuk Ecza Deposu Margins & Growth Rates

Selcuk Ecza Deposu's last 12 month revenue growth is 20%

Selcuk Ecza Deposu's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $28K for the same period.

Selcuk Ecza Deposu's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Selcuk Ecza Deposu's rule of X is 53% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Selcuk Ecza Deposu and other 15K+ public comps

Selcuk Ecza Deposu Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 20% XXX 24% XXX XXX XXX
EBITDA Margin 3% XXX 5% XXX XXX XXX
EBITDA Growth 29% XXX 52% XXX XXX XXX
Rule of 40 22% XXX 25% XXX XXX XXX
Bessemer Rule of X XXX XXX 53% XXX XXX XXX
Revenue per Employee XXX XXX $0.5M XXX XXX XXX
Opex per Employee XXX XXX $28K XXX XXX XXX
S&M Expenses to Revenue XXX XXX 5% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 6% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Selcuk Ecza Deposu Public Comps

See public comps and valuation multiples for Pharmacies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Sigma Healthcare XXX XXX XXX XXX XXX XXX
MedPlus India XXX XXX XXX XXX XXX XXX
SC Ropharma XXX XXX XXX XXX XXX XXX
Brasil Pharma XXX XXX XXX XXX XXX XXX
D1000 Varejo Farma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Selcuk Ecza Deposu M&A and Investment Activity

Selcuk Ecza Deposu acquired  XXX companies to date.

Last acquisition by Selcuk Ecza Deposu was  XXXXXXXX, XXXXX XXXXX XXXXXX . Selcuk Ecza Deposu acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Selcuk Ecza Deposu

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Selcuk Ecza Deposu

When was Selcuk Ecza Deposu founded? Selcuk Ecza Deposu was founded in 1970.
Where is Selcuk Ecza Deposu headquartered? Selcuk Ecza Deposu is headquartered in Turkey.
How many employees does Selcuk Ecza Deposu have? As of today, Selcuk Ecza Deposu has 6.5K+ employees.
Is Selcuk Ecza Deposu publicy listed? Yes, Selcuk Ecza Deposu is a public company listed on IST.
What is the stock symbol of Selcuk Ecza Deposu? Selcuk Ecza Deposu trades under SELEC ticker.
When did Selcuk Ecza Deposu go public? Selcuk Ecza Deposu went public in 2006.
Who are competitors of Selcuk Ecza Deposu? Similar companies to Selcuk Ecza Deposu include e.g. Sigma Healthcare, MedPlus India, SC Ropharma, Brasil Pharma.
What is the current market cap of Selcuk Ecza Deposu? Selcuk Ecza Deposu's current market cap is $1.1B
What is the current revenue of Selcuk Ecza Deposu? Selcuk Ecza Deposu's last 12 months revenue is $3.9B.
What is the current revenue growth of Selcuk Ecza Deposu? Selcuk Ecza Deposu revenue growth (NTM/LTM) is 20%.
What is the current EV/Revenue multiple of Selcuk Ecza Deposu? Current revenue multiple of Selcuk Ecza Deposu is 0.3x.
Is Selcuk Ecza Deposu profitable? Yes, Selcuk Ecza Deposu is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Selcuk Ecza Deposu? Selcuk Ecza Deposu's last 12 months EBITDA is $130M.
What is Selcuk Ecza Deposu's EBITDA margin? Selcuk Ecza Deposu's last 12 months EBITDA margin is 3%.
What is the current EV/EBITDA multiple of Selcuk Ecza Deposu? Current EBITDA multiple of Selcuk Ecza Deposu is 7.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.